Carriers vary on biofeedback, but all require failed PME first

Article Overview

This article explains how different carriers approach coverage for biofeedback therapy, especially when it is used for incontinence. It is aimed at coding and reimbursement professionals who need to understand the general policy landscape, the distinction between the CPT services discussed, and the ICD-9 diagnosis references commonly tied to payer medical necessity review. The piece also summarizes why prior failed pelvic muscle exercise therapy matters in coverage decisions and notes that payer policies may differ by diagnosis category and jurisdiction.